ATE17825T1 - Verfahren zur herstellung von mit radionukliden markierten proteinen, insbesondere von antikoerpern oder antikoerperfragmenten. - Google Patents

Verfahren zur herstellung von mit radionukliden markierten proteinen, insbesondere von antikoerpern oder antikoerperfragmenten.

Info

Publication number
ATE17825T1
ATE17825T1 AT82201602T AT82201602T ATE17825T1 AT E17825 T1 ATE17825 T1 AT E17825T1 AT 82201602 T AT82201602 T AT 82201602T AT 82201602 T AT82201602 T AT 82201602T AT E17825 T1 ATE17825 T1 AT E17825T1
Authority
AT
Austria
Prior art keywords
acid
antibody fragments
labelled proteins
radionuklide
processes
Prior art date
Application number
AT82201602T
Other languages
English (en)
Inventor
Wilhelmus Theodorus Goedemans
Original Assignee
Mallinckrodt Diagnostica Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19838626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE17825(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mallinckrodt Diagnostica Bv filed Critical Mallinckrodt Diagnostica Bv
Application granted granted Critical
Publication of ATE17825T1 publication Critical patent/ATE17825T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT82201602T 1981-12-29 1982-12-14 Verfahren zur herstellung von mit radionukliden markierten proteinen, insbesondere von antikoerpern oder antikoerperfragmenten. ATE17825T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8105880 1981-12-29
EP82201602A EP0083129B1 (de) 1981-12-29 1982-12-14 Verfahren zur Herstellung von mit Radionukliden markierten Proteinen, insbesondere von Antikörpern oder Antikörperfragmenten

Publications (1)

Publication Number Publication Date
ATE17825T1 true ATE17825T1 (de) 1986-02-15

Family

ID=19838626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82201602T ATE17825T1 (de) 1981-12-29 1982-12-14 Verfahren zur herstellung von mit radionukliden markierten proteinen, insbesondere von antikoerpern oder antikoerperfragmenten.

Country Status (7)

Country Link
EP (1) EP0083129B1 (de)
JP (1) JPS58126817A (de)
AT (1) ATE17825T1 (de)
AU (1) AU562619B2 (de)
CA (1) CA1222691A (de)
DE (1) DE3269028D1 (de)
DK (1) DK574482A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443426A (en) * 1982-06-14 1984-04-17 Yale University Blood agent
CA1223831A (en) * 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
EP0176288B1 (de) * 1984-09-21 1990-05-09 The Dow Chemical Company Aminocarbonsäurekomplexe zur Behandlung von Knochentumoren
EP0210684A1 (de) * 1985-07-31 1987-02-04 MALLINCKRODT, INC.(a Missouri corporation) Ein eine radioaktive Metallzusammensetzung enthaltendes Präparat für Radiodiagnostika
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021567A (en) * 1987-09-24 1991-06-04 Abbott Laboratories 8-hydroxyquinoline chelating agents
US5245026A (en) * 1987-09-24 1993-09-14 Abbott Laboratories Metal containing 8-hydroxyquinoline chelating agents
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
EP0709100A1 (de) * 1994-09-30 1996-05-01 Nihon Medi-Physics Co., Ltd. Kontrastmittel mit mehreren Detektionsgruppen pro Molekül
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) * 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same

Also Published As

Publication number Publication date
DK574482A (da) 1983-06-30
JPS58126817A (ja) 1983-07-28
DE3269028D1 (en) 1986-03-20
EP0083129A1 (de) 1983-07-06
EP0083129B1 (de) 1986-02-05
AU9151082A (en) 1983-07-07
CA1222691A (en) 1987-06-09
AU562619B2 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
ATE17825T1 (de) Verfahren zur herstellung von mit radionukliden markierten proteinen, insbesondere von antikoerpern oder antikoerperfragmenten.
Butkowski et al. Primary Structure of Human Prethrombin 2 and cw-Thrombin
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ES8701497A1 (es) Un metodo para preparar un complejo inmunogeno
ATE124269T1 (de) Verfahren zur herstellung eines mit metall- radionuklid-markierten proteins.
DE3584460D1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
AU564620B2 (en) Peptides and protein-peptide complexes
PT82428B (pt) Metodo para a producao de urocinase resistente a proteases
ATE123761T1 (de) Verfahren zur herstellung von 2,4,6-trijod-5- aminoisophthalsäureamid verbindungen.
SE8103198L (sv) Forfarande for framstellning av antikroppar
ATE6925T1 (de) Verfahren zur reinigung von gallium enthaltenden loesungen.
ATE41162T1 (de) Verfahren zur herstellung von insulin-derivaten.
DE3889851D1 (de) Verfahren und Materialien zur Herstellung der Lösungen von metallmarkierten Antikörpern.
DE3585084D1 (de) Verfahren zur reinigung eines proteins.
EP0412012A1 (de) Technetium-99m-markierte Polypeptide und ihre Anwendungen in der Bilderzeugung
ATE23036T1 (de) Verfahren zur extraktion von aromatischen aminosaeuren aus waessriger phase.
ATE15109T1 (de) Verfahren zur herstellung einer chromogenen reaktionsmischung zur bestimmung der eisenkonzentration und -bindungskapazitaet von serum sowie die dabei erhaltene chromogene reaktionsmischung.
ATE15209T1 (de) Verfahren zur herstellung von carbonsaeureamidgruppen enthaltenden verbindungen, insbesondere von peptiden.
Astrup et al. Fractional precipitation of serum proteins by means of specific anions
Garvey [20] Antibodies to metallothionein
JP2019112312A (ja) ジルコニウムの標識方法
EP0066246A3 (de) Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
KR910005887A (ko) 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도
DE68922850D1 (de) Verfahren zur herstellung von 2,4,6-triiodo-5-amino-n-alkyl-isophthalsäure.
EP0498333B1 (de) Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee